Also trades as: MBXBF (OTC) · $vol 0M
MBX.TO TSX
Microbix Biosystems Inc.
1W: +1.7%
1M: +1.7%
3M: +0.0%
YTD: +30.4%
1Y: +27.7%
3Y: -6.2%
5Y: -53.9%
C$0.30 ($0.21)
-0.01 (-3.23%)
Weekly Expected Move ±6.6%
C$0
C$0
C$0
C$0
C$0
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Income Trends
Revenue
$19M
-26.8% ▼
5Y CAGR: +12.0%
Gross Profit
$10M
-36.0% ▼
5Y CAGR: +16.2%
Operating Income
-$2M
-140.4% ▼
Net Income
-$2M
-163.8% ▼
EPS (Diluted)
$-0.02
-162.9% ▼
EBITDA
$428K
-93.1% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $19M | $19M | $17M | $25M | $19M |
| YoY Growth | +76.7% | +2.6% | -13.4% | +53.8% | -26.8% |
| Cost of Revenue | $8M | $8M | $9M | $10M | $9M |
| Gross Profit | $11M | $11M | $7M | $15M | $10M |
| Gross Margin | 59.4% | 58.3% | 45.3% | 60.6% | 53.0% |
| R&D Expenses | $1M | $2M | $2M | $2M | $2M |
| SG&A Expenses | $5M | $7M | $8M | $9M | $9M |
| Operating Expenses | $6M | $9M | $10M | $11M | $11M |
| Operating Income | $5M | $3M | -$3M | $4M | -$2M |
| Operating Margin | 26.0% | 14.1% | -16.6% | 15.4% | -8.5% |
| Interest Expense | $2M | $827K | $839K | $922K | $950K |
| Income Before Tax | $3M | $2M | -$39K | $4M | -$2M |
| Tax Expense | $2M | $77K | $0 | $151K | -$56K |
| Net Income | $2M | $2M | -$39K | $4M | -$2M |
| Net Margin | 8.8% | 9.4% | -0.2% | 13.9% | -12.1% |
| EPS (Diluted) | $0.01 | $0.01 | $-0.00 | $0.03 | $-0.02 |
| EBITDA | $6M | $4M | $2M | $6M | $428K |
| Shares Outstanding | 142M | 142M | 138M | 137M | 139M |